The goal of this observational study is to evaluate whether perioperative hyperoxia (FiOâ‚‚ \> 0.8), compared to conventional oxygen therapy (FiOâ‚‚ \< 0.4), is associated with increased cancer recurrence and mortality in patients undergoing curative elective colorectal cancer surgery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Recurrence-free Survival
Timeframe: Follow-up period (at least 3 years since surgery)